Ligand Pharmaceuticals (LGND) News Today $159.08 +1.77 (+1.13%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$159.07 -0.01 (-0.01%) As of 08/22/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock LGND Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Receives Consensus Recommendation of "Buy" from Brokerages2 hours ago | americanbankingnews.comInvesco Ltd. Purchases 8,473 Shares of Ligand Pharmaceuticals Incorporated $LGNDAugust 23 at 4:16 AM | marketbeat.comA Fresh Look at Ligand Pharmaceuticals (LGND) Valuation Following $400 Million Convertible Note Offering and Capital Structure ShiftAugust 22 at 10:33 AM | finance.yahoo.comConnor Clark & Lunn Investment Management Ltd. Reduces Position in Ligand Pharmaceuticals Incorporated $LGNDAugust 22 at 3:38 AM | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Sold by Vanguard Group Inc.August 22 at 3:18 AM | marketbeat.comLigand Pharmaceuticals Incorporated $LGND Shares Bought by Aberdeen Group plcAugust 20, 2025 | marketbeat.comLigand Pharmaceuticals Inc (LGND) Announces Participation in Upcoming Investor Conferences | ...August 19, 2025 | gurufocus.comLigand Pharmaceuticals to Participate in Upcoming Investor Conferences in September 2025August 19, 2025 | quiverquant.comQLigand to Participate in September Investor ConferencesAugust 19, 2025 | globenewswire.comRussell Investments Group Ltd. Has $14.23 Million Stake in Ligand Pharmaceuticals Incorporated $LGNDAugust 19, 2025 | marketbeat.comPublic Sector Pension Investment Board Grows Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)August 18, 2025 | marketbeat.comLigand Pharma Completes $460M Convertible Notes OfferingAugust 14, 2025 | msn.comLigand Announces Closing of Convertible Senior Notes OfferingAugust 14, 2025 | globenewswire.comUS Bancorp DE Purchases 3,301 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)August 14, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High - Should You Buy?August 13, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Shares Gap Down - Should You Sell?August 12, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Shares Purchased by Townsquare Capital LLCAugust 12, 2025 | marketbeat.comAnalysts Are Bullish on Top Healthcare Stocks: Insmed (INSM), Ligand Pharma (LGND)August 12, 2025 | theglobeandmail.comLigand Pharmaceuticals to offer $400M convertible senior notes in private placementAugust 12, 2025 | msn.comLGND: Getting In Tune with MedTechAugust 12, 2025 | msn.comLigand prices $400M convertible debt offeringAugust 12, 2025 | msn.comLigand Pharmaceuticals Inc (LGND) Announces Pricing of $400 Million Convertible Senior Notes | ...August 12, 2025 | gurufocus.comLigand Pharmaceuticals Inc (LGND) Announces Pricing of $400 Million Convertible Senior Notes | ...August 12, 2025 | gurufocus.comLigand Pharmaceuticals Prices $400 Million Convertible Senior Notes Due 2030August 11, 2025 | quiverquant.comQLigand Pharmaceuticals prices $400 million convertible notes offeringAugust 11, 2025 | investing.comLigand Announces Pricing of $400 Million Convertible Senior Notes OfferingAugust 11, 2025 | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Posts Earnings Results, Beats Expectations By $0.06 EPSAugust 11, 2025 | marketbeat.comLigand Announces Proposed Offering of $400 Million of Convertible Senior Notes Due 2030August 11, 2025 | globenewswire.comRoyal Bank Of Canada Issues Positive Forecast for Ligand Pharmaceuticals (NASDAQ:LGND) Stock PriceAugust 10, 2025 | marketbeat.comLigand Pharmaceuticals (NASDAQ:LGND) Stock Rating Upgraded by Wall Street ZenAugust 10, 2025 | marketbeat.comLigand (LGND) Q2 Revenue Jumps 15%August 8, 2025 | theglobeandmail.comLigand Pharmaceuticals (NASDAQ:LGND) Updates FY 2025 Earnings GuidanceAugust 8, 2025 | marketbeat.comLigand Pharmaceuticals Inc (LGND) Q2 2025 Earnings Call Highlights: Robust Royalty Growth and ...August 8, 2025 | gurufocus.comLigand Pharmaceuticals Incorporated 2025 Q2 - Results - Earnings Call PresentationAugust 7, 2025 | seekingalpha.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 12-Month High - Still a Buy?August 7, 2025 | marketbeat.comLigand Pharmaceuticals Q2 2025 Earnings: Revenue Surpasses Estimates at $47. ...August 7, 2025 | gurufocus.comLigand Reports Second Quarter 2025 Financial Results and Raises GuidanceAugust 7, 2025 | globenewswire.comJohn W. Kozarich Sells 467 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) StockAugust 6, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Director John W. Kozarich Sells 467 SharesAugust 6, 2025 | insidertrades.com2,519 Shares in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) Bought by Pacer Advisors Inc.August 2, 2025 | marketbeat.comOppenheimer Forecasts Strong Price Appreciation for Ligand Pharmaceuticals (NASDAQ:LGND) StockJuly 31, 2025 | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Invests $2.22 Million in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 31, 2025 | marketbeat.comLigand Pharmaceuticals (LGND) Expected to Announce Quarterly Earnings on ThursdayJuly 31, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Given Average Recommendation of "Buy" by AnalystsJuly 30, 2025 | marketbeat.comLigand Pharmaceuticals Incorporated (NASDAQ:LGND) Holdings Decreased by Essex Investment Management Co. LLCJuly 29, 2025 | marketbeat.comVictory Capital Management Inc. Has $2.91 Million Stock Holdings in Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 29, 2025 | marketbeat.comEnvestnet Asset Management Inc. Sells 60,587 Shares of Ligand Pharmaceuticals Incorporated (NASDAQ:LGND)July 28, 2025 | marketbeat.comLigand Pharmaceuticals Inc (LGND) Announces Upcoming Q2 2025 Financial Results Release | LGND ...July 24, 2025 | gurufocus.comLigand to Report Second Quarter 2025 Financial Results on August 7, 2025July 24, 2025 | globenewswire.comLigand Pharmaceuticals (NASDAQ:LGND) Sets New 52-Week High - Time to Buy?July 22, 2025 | marketbeat.com Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address LGND Media Mentions By Week LGND Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. LGND News Sentiment▼1.320.69▲Average Medical News Sentiment LGND News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. LGND Articles This Week▼116▲LGND Articles Average Week Get Ligand Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for LGND and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ADMA News Today ANIP News Today BMRN News Today EXEL News Today EXAS News Today HALO News Today MDGL News Today RGEN News Today IONS News Today ALKS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:LGND) was last updated on 8/24/2025 by MarketBeat.com Staff From Our PartnersNations are at war over what’s in this boxA resource known as Element 29 is quickly becoming one of the most sought-after materials on the planet. Goldm...Behind the Markets | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredTrump’s betrayal exposedTrump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTrump’s “new dollar” could shock Americans"I Made Millions in the Tech Boom. Here's Where I'd Put My Money Today" This man has called some of the big...Stansberry Research | SponsoredHere's the last trade you should make before heading out for the weekend tomorrow.On a quiet Friday afternoon, one trader spotted an overlooked stock. He bought shares. He shut down his ...Timothy Sykes | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access